These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36334263)

  • 1. Hyperparathyroidism in a Large Cohort of Chinese Patients With Tumor-induced Osteomalacia.
    Ni X; Liu W; Zhang D; Li X; Chi Y; Feng J; Jin C; Pang Q; Gong Y; Cui L; Jiajue R; Yu W; Wu H; Huo L; Liu Y; Jin J; Zhou X; Lv W; Zhou L; Xia Y; Wang O; Li M; Xing X; Jiang Y; Xia W
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1224-1235. PubMed ID: 36334263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of hyperparathyroidism secondary to tumor-induced osteomalacia.
    Yang Y; Jin P; Zhang S; Chen K; He H; Mo Z; Yuan J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1937-1944. PubMed ID: 38448388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinacalcet in the management of tumor-induced osteomalacia.
    Geller JL; Khosravi A; Kelly MH; Riminucci M; Adams JS; Collins MT
    J Bone Miner Res; 2007 Jun; 22(6):931-7. PubMed ID: 17352646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of secondary and tertiary hyperparathyroidism--surgical viewpoints].
    Klempa I
    Chirurg; 1999 Oct; 70(10):1089-101. PubMed ID: 10550338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of tumor-induced osteomalacia due to an intracranial tumor by fractionated stereotactic radiotherapy.
    Tarasova VD; Trepp-Carrasco AG; Thompson R; Recker RR; Chong WH; Collins MT; Armas LA
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4267-72. PubMed ID: 24014621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic polymorphisms of XPR1 and SCL34A3 are associated with Fanconi syndrome in Chinese patients of tumor-induced osteomalacia.
    Jiang Y; Li X; Feng J; Li M; Wang O; Xing XP; Xia WB
    J Endocrinol Invest; 2021 Apr; 44(4):773-780. PubMed ID: 32725396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deliberate total parathyroidectomy: a potentially novel therapy for tumor-induced hypophosphatemic osteomalacia.
    Bhadada SK; Palnitkar S; Qiu S; Parikh N; Talpos GB; Rao SD
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4273-8. PubMed ID: 23956343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-induced osteomalacia.
    Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
    Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term use of burosumab for the treatment of tumor-induced osteomalacia.
    Crotti C; Zucchi F; Alfieri C; Caporali R; Varenna M
    Osteoporos Int; 2023 Jan; 34(1):201-206. PubMed ID: 35925260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide Is Ineffective in Treating Tumor-Induced Osteomalacia: Results of a Short-Term Therapy.
    Ovejero D; El-Maouche D; Brillante BA; Khosravi A; Gafni RI; Collins MT
    J Bone Miner Res; 2017 Aug; 32(8):1667-1671. PubMed ID: 28459498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor induced osteomalacia: A single center experience on 17 patients.
    Crotti C; Bartoli F; Coletto LA; Manara M; Marini E; Daolio PA; Parafioriti A; Armiraglio E; Zucchi F; Sinigaglia L; Caporali R; Varenna M
    Bone; 2021 Nov; 152():116077. PubMed ID: 34175499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in the management of tumor-induced osteomalacia (TIO).
    Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
    Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women.
    Youssef Y; Richards WO; Sekhar N; Kaiser J; Spagnoli A; Abumrad N; Torquati A
    Surg Endosc; 2007 Aug; 21(8):1393-6. PubMed ID: 17318692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rickets guidance: part II-management.
    Haffner D; Leifheit-Nestler M; Grund A; Schnabel D
    Pediatr Nephrol; 2022 Oct; 37(10):2289-2302. PubMed ID: 35352187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia.
    Jan de Beur SM; Minisola S; Xia WB; Abrahamsen B; Body JJ; Brandi ML; Clifton-Bligh R; Collins M; Florenzano P; Houillier P; Imanishi Y; Imel EA; Khan AA; Zillikens MC; Fukumoto S
    J Intern Med; 2023 Mar; 293(3):309-328. PubMed ID: 36511653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-induced osteomalacia.
    Florenzano P; Gafni RI; Collins MT
    Bone Rep; 2017 Dec; 7():90-97. PubMed ID: 29021995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypophosphatemia related to a neuro-endocrine tumor of the pancreas: A case report.
    Pickering ME; Bouvier D; Puravet A; Soubrier M; Sapin V; Oris C
    Clin Biochem; 2022 Jun; 104():62-65. PubMed ID: 35337828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study.
    Molinari P; Regalia A; Leoni A; Campise M; Cresseri D; Cicero E; Vettoretti S; Nardelli L; Brigati E; Favi E; Messa P; Castellano G; Alfieri CM
    Front Med (Lausanne); 2023; 10():1221086. PubMed ID: 37636567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced Osteomalacia in a Boy with Maxillary Ossifying Fibroma.
    Thi HN; Manh CP; Tuan LT; Le Thi LA; Thanh NN; Vilaiyuk S
    J Clin Res Pediatr Endocrinol; 2023 Nov; 15(4):421-425. PubMed ID: 35135186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.